Applying new research criteria for diagnosis of early Alzheimer's disease: sex and intelligence matter.
Alzheimer's disease (AD) can be diagnosed according to new research criteria proposed recently (Dubois et al., 2007). Diagnosis is made on grounds of episodic memory deficits and one pathological biomarker: cerebrospinal fluid (CSF) or structural/functional imaging. Goal was to investigate the dependence of episodic memory function on material (verbal, visuospatial), gender and premorbid intellectual ability (IQ). The new research criteria of AD were applied retrospectively using data of 68 patients (Mini-Mental-Status Examination, MMSE >/= 22) from a university memory clinic. Women with lower IQ performed worse on visuospatial episodic memory than women with higher IQ and men with the same IQ. Thus, women with lower IQ appear to be particularly vulnerable to visuospatial episodic memory deficits despite similar CSF tau values indicating a similar activity of the neurodegenerative process. Gender, premorbid IQ, and visuospatial material need to be considered in the assessment of episodic memory breakdown applying the newly proposed research criteria for the diagnosis of AD.
Beinhoff
U
U
Department of Psychiatry, Mental Health and Old Age Psychiatry, Charité Medical University, 14050 Berlin, Germany.
Tumani
H
H
Riepe
M W
MW
J Clin Exp Neuropsychol. 1997 Oct;19(5):655-66
9408796
J Clin Exp Neuropsychol. 1999 Aug;21(4):553-8
10550812
Mem Cognit. 2004 Oct;32(7):1160-9
15813497
Ann Neurol. 2006 Mar;59(3):512-9
16372280
Neuropsychologia. 2004;42(4):555-62
14728927
Arch Gen Psychiatry. 1983 Jul;40(7):812
6860082
Neurology. 1999 Jan 1;52(1):78-84
9921852
Psychol Med. 1997 Nov;27(6):1337-44
9403905
Ann Neurol. 2002 May;51(5):567-77
12112102
Dement Geriatr Cogn Disord. 2006;22(1):27-34
16679762
J Int Neuropsychol Soc. 2002 Mar;8(3):448-60
11939702
Neurology. 2000 Aug 8;55(3):370-6
10932270
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2007 Jul;14(4):394-416
17612815
Neurosci Lett. 2007 May 23;419(1):18-22
17482358
Ann Neurol. 1995 Oct;38(4):643-8
7574461
JAMA. 1994 Apr 6;271(13):1004-10
8139057
Lancet Neurol. 2006 Mar;5(3):228-34
16488378
Lancet Neurol. 2003 Oct;2(10):605-13
14505582
Science. 2002 Oct 25;298(5594):789-91
12399581
Neurology. 1999 Dec 10;53(9):1942-7
10599762
J Int Neuropsychol Soc. 2007 Sep;13(5):821-31
17697413
Ann Neurol. 2002 Apr;51(4):491-8
11921055
Lancet Neurol. 2007 Aug;6(8):734-46
17616482
Am J Psychiatry. 1997 Feb;154(2):165-72
9016263
J Child Neurol. 1999 Feb;14(2):98-107
10073431
J Am Geriatr Soc. 1999 Feb;47(2):159-64
9988286
Ann Neurol. 1995 Oct;38(4):649-52
7574462
Brain Cogn. 2005 Mar;57(2):120-6
15708201
Neuropsychology. 1999 Oct;13(4):590-7
10527068
Neurosci Lett. 2003 Mar 20;339(2):99-102
12614904
J Neurol. 2008 Jan;255(1):117-22
18202815
Mem Cognit. 1997 Nov;25(6):801-11
9421566
J Int Neuropsychol Soc. 2003 Jan;9(1):97-102
12570363
Neurology. 2001 Dec 26;57(12):2236-42
11756603
Gerontology. 2004 Jan-Feb;50(1):35-8
14654725
Neurology. 1984 Jul;34(7):939-44
6610841
Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13
12764551
J Neurochem. 1993 Nov;61(5):1828-34
8228996
Neuropsychology. 2001 Apr;15(2):165-73
11324860
Arch Neurol. 2001 Dec;58(12):1985-92
11735772
Brain Cogn. 2003 Jul;52(2):231-8
12821106
Neurology. 1992 Jan;42(1):115-9
1734291
Nat Neurosci. 2000 Apr;3(4):404-8
10725932
J Clin Psychol. 1988 May;44(3):403-11
3384968
Am J Public Health. 1998 Sep;88(9):1337-42
9736873
Mol Psychiatry. 2003 Mar;8(3):343-7
12660807
Nature. 2002 Jul 18;418(6895):291
12124613